Arandi 100mg Injection
PDF Leaflet Revision Date: 16 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of invasive candidiasis, including candidaemia, in adults.
Dosage (summary)
200 mg loading dose on day 1, followed by 100 mg daily.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; unknown if excreted in breast milk.
Key Drug Interactions
- Ciclosporin
- Voriconazole
- Tacrolimus
- Amphotericin B
- Rifampicin
Contraindications
- Hypersensitivity to anidulafungin
- Pregnancy
- Lactation
- Children under 18
Common side effects
- Rash
- Pruritus
- Dyspnoea
- Hypotension
- Flushing
Counselling Points
- Monitor for infusion-related reactions
- Do not use in children
- Report any allergic reactions
Serious warnings
- Anaphylactic reactions
- Infusion-related reactions
- Monitor hepatic function
Important Disclaimer
The Arandi 100mg Injection professional information leaflet below is the property of Sandoz Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
